The ODA is intended to provide incentives for Orphan Drug development and to defray the costs of qualified clinical testing expenses incurred in connection with the development of drugs for rare diseases and conditions.
View this resource Bookmark this resource
US Orphan Drug Designation
Published by IRDiRC
Regulatory AffairsEarly Access SupportOrphan Drug DesignationRegulatory AdviceOrphan Drug Incentive